Millipore has launched a product as part of its collaboration with Roka Bioscience to develop faster, more robust tests for contaminants in pharmaceutical and biotechnology manufacturing. The Milliprobe Detection System for Mycoplasma is said to be the first solution of its kind for the early detection of mycoplasma contamination in the highly regulated biopharmaceutical manufacturing industry. The system is also said to cut detection time from between 28 and 35 days (for traditional culture-based technology) to four hours.Faster and more robust detection enables biopharmaceutical manufacturers to test more frequently and take corrective action earlier in the production process, reducing financial risks and optimising product yields. Roland Heinrich, Millipore vice president, Process Monitoring, said: 'It includes a novel Millipore sample-preparation device designed to handle complex bioreactor samples in larger volumes than other mycoplasma testing products.
'It also includes Gen-Probe's Background Reduction Technology, which protects the assay from contamination that can cause false positive results.
